Associate Director, Biostatistics @ Alexion Pharmaceuticals, Inc. | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
Associate Director, Biostatistics jobs in Boston, MAH1B Visa Sponsored Associate Director, Biostatistics jobs in Boston, MA
Be an early applicantLess than 25 applicants
company-logo

Alexion Pharmaceuticals, Inc. · 1 week ago

Associate Director, Biostatistics

Wonder how qualified you are to the job?

ftfMaximize your interview chances
BiotechnologyHealth Care
check
H1B Sponsorship
check
Comp. & Benefits

Insider Connection @Alexion Pharmaceuticals, Inc.

Discover valuable connections within the company who might provide insights and potential referrals, giving your job application an inside edge.

Responsibilities

Lead and manage team of internal and external biostatistics and statistical programming resources supporting studies and programs for identified therapeutic area(s) or phase(s) of development. Manage assignments and priorities of team members.
Ensure accurate, statistically valid deliverables included in protocols, statistical analysis plans, study reports, manuscripts, and regulatory submission documents.
Coordinate achievement of major statistical deliverables and milestones in collaboration with other functions.
Leverage standardization to maximize global data integration and interpretability.
Provide statistical leadership and support for feasibility assessments, clinical development plans, complex study designs, regulatory meetings, submissions and follow up.
Responsible for providing statistical leadership for preparation of marketing applications (NDA/BLA) to FDA, EMA or other worldwide regulatory agencies.
Apply innovative statistical approaches to the design of studies and to the analysis/reporting of study results (e.g., modeling and simulation, adaptive design and /or Bayesian approaches)
Keeps abreast of literature/advancements in science/medicine/technology in own and related fields of the drug development program.
Monitors project progress and ensures proper resource allocation for successful project deliverables against goals and timelines.

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

Statistical MethodologyClinical Trials DesignBayesian ModelingAdaptive DesignRegulatory Requirements KnowledgeBLA/NDA ExperienceECTD SubmissionsStatistical Software Programs (SAS)CDISC Requirements KnowledgeSDTMADaM Communication SkillsInterpersonal SkillsFlexibleWell-Organized Work Under Pressure

Required

A PhD in Statistics/Biostatistics and at least 7 years of relevant pharmaceutical experience or a MSc in Statistics/Biostatistics and at least 10 years of relevant pharmaceutical experience
Comprehensive knowledge of statistical methodology in design and analysis of clinical trials including Bayesian modeling and adaptive design
Knowledge of regulatory requirements relating to clinical development of drugs and biologics
BLA/NDA experience including eCTD submissions
Working knowledge of major statistical software programs including SAS
Knowledge of CDISC requirements for SDTM and ADaM
Excellent verbal and written communication skills, and excellent inter-personal skills
Flexible, well-organized, and possess the ability to work well under pressure

Preferred

PhD in Statistics/Biostatistics preferred

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca.

H1B Sponsorship

Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Trends of Total Sponsorships
2023 (34)
2022 (30)
2021 (26)
2020 (18)

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired· by AstraZeneca ($39B)
1999-02-12Post Ipo Equity· $5.8M
1996-03-08IPO· nasdaq:ALXN

Leadership Team

leader-logo
Ludwig N. Hantson
Chief Executive Officer
linkedin
leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
Company data provided by crunchbase
logo

Orion

Your AI Copilot